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broad-spectrum (MMP-2, -3, -8, -9 and -13) matrix metallo-
proteinase (MMP) inhibitor in the rat meniscal tear model of
Osteoarthritis (OA). In order to assess if MMP-13 was a critical
enzyme responsible for cartilage degradation in this model, a
non-selective MMP inhibitor (MMPI) was compared to a more-
selective inhibitor MMP-13 (MMP-13SI).
Methods: All animal studies were performed at Bolder BioPath
with IACUC approval. Lewis rats were gavaged twice daily with
vehicle, 30 mg/kg MMPI or 30 mg/kg MMP-13SI, starting the
day prior to surgery, with 20 rats per group. Surgery consisted of
sectioning of the medial collateral ligament and medial meniscus.
At 3 weeks post-surgery, plasma was taken for PK analysis, rats
euthanized and the knees harvested for histologic evaluation.
Results: The MMPI gave comparable efficacy to other broad-
spectrum MMP inhibitors, and was consistent across 3 separate
studies. PK analysis showed excellent exposure for both com-
pounds. Despite excellent PK, the MMP-13SI showed no efficacy
in this model.
Conclusions: Several studies using broad-spectrum MMP in-
hibitors (including MMP-13) have shown efficacy in-vivo, but
none have been reported with selective MMP-13 inhibitors. This
is the first published study to show that a more MMP-13 selective
inhibitor, with good PK, was not efficacious in the rat meniscal
tear model of OA.
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Purpose: To evaluate the effect of a polysaccharide derived from
Guar gum (GG) given intra-articularly (i. art.) in joint pain in an
osteoarthritis (OA) model in rats.
Methods: Wistar rats were subjected to ACLT (OA group). Joint
pain was measured using the test for articular incapacitation,
until 7d. The OA group was compared to false-operated (sham).
GG (100μg), gel or solution, or Hylan G-F 20 (100μg) were given
i.art. at day 4 after ACLT and joint pain was recorded daily, until
sacrifice, at day 7. Controls received saline i.art.
Results: Animals of the OA group presented significant joint
pain as compared to sham (P<0.001). GG, either as a gel or
solution, significantly inhibited joint pain. This effect was similar
to the inhibition achieved with Hylan G-F20.
Conclusions: This is the first demonstration that a galactoman-
nan derived from GG is antinociceptive in experimental OA. The
antinociception is independent of the colloidal state. We propose
that the analgesic benefit of viscosupplementation may be due
to an intrinsic carbohydrate-mediated mechanism, rather than to
the rheologic properties of the material.
Biomarkers
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Purpose: The purpose of this study was to examine the utility
of using urea concentrations for determining synovial fluid (SF)
joint volume.
Methods: Knee joint SF was collected either directly or by saline
lavage from both knees of 140 human subjects. SF was aspi-
rated directly from 165 knees and by lavage from 110 knees.
No SF was obtainable from 5 joints. Serum was obtained im-
mediately prior to SF aspiration. All participants met ACR and
radiographic (KL grade ≥ 1) criteria for symptomatic OA of at
least one knee. Subjects with knee replacement or bilateral knee
OA of KL grade 4 were excluded. Participants were asked to rate
individual knee pain, aching or stiffness as none, mild, moderate
or severe. SF and serum urea levels were determined using a
specific enzymatic method run on an automated CMA600 ana-
lyzer. Cell counts were performed on direct SF aspirates when
volume permitted. The formula for calculating SF joint volume
was as follows: Vj=CD(VI)/(C-CD) with Vj=volume SF in entire
joint, CD=concentration urea in diluted (lavage) SF, VI=volume
saline injected into joint, and C=concentration urea in undiluted
(neat) SF derived below where C=0.897(Cs), Cs=concentration
urea in serum.
Results: Subject ages ranged from 35-85 years with a mean
of 64 and a median of 66. There was an excellent correlation
(r2=0.8588) between SF and serum urea in the direct aspirates
(Fig. 1) with a ratio of 0.897 (SF/serum). As expected neither
urea levels nor the SF/serum ratio showed any correlation with KL
grade, or cell count. While urea levels increased with age there
was no change in the ratio. Intraarticular SF volumes calculated
for the lavaged knees ranged from 0.555ml to 71.71ml with a me-
dian volume of 3.048ml. There was no correlation of SF volume
to KL grade but there was a positive correlation (p=0.001) be-
tween SF volume and self reported individual knee pain (Fig. 2).
Fig. 1. Correlation of SF and serum urea in direct aspirates.
Fig. 2. Knee joint SF volume by pain.
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Conclusions: SF derived markers are often used to monitor
tissue degradation in joint diseases such as Rheumatoid Arthri-
tis and Osteoarthritis. Monitoring of a single index joint is most
directly done by analysis of joint fluid. At times it becomes desir-
able to estimate synovial fluid volume to determine total amount
of biomarker in the joint. This may be of special use in cases of
acute inflammation with effusion. Urea is a small molecule (60
Da) which readily diffuses between blood and synovial fluid. It is
neither metabolised nor produced by any joint tissue. Our urea
results for direct aspirates indicates an equilibrium state between
serum and SF with regard to the water fraction. This equilibrium
exists regardless of disease status (KL grade), inflammation (cell
count), or age, making it possible to calculate intraarticular vol-
ume of lavaged joints based upon this urea method. Most of the
joint volumes we calculated fell within the previously reported
range for normal knees of 0.5-4ml. The positive correlation be-
tween SF volume and knee symptoms provides independent
confirmation of the recently reported association of knee pain
and stiffness with moderate and large joint effusions by magnetic
resonance imaging. This correlation reinforces the clinical utility
of this method for quantifying SF volume.
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Purpose: The objective of this study was to measure serum and
urine biomarkers indicative of joint pathology in participants en-
rolled in the Genetics of Generalized Osteoarthritis (GoGo) study,
to determine change in biomarkers relative to OA disease sever-
ity and progression as determined by change in radiographic
status.
Methods: Participants were selected based on radiographic ev-
idence considered to be indicative of mild to moderate OA in
the knees, as determined by Kellgren Lawrence grade (KL grade
1, 2, 3) and having a minimum joint space (MJS) of ≥0.5mm.
Osteophytes (Os) and joint space narrowing were scored (0-3)
using a standard atlas. Serum and urine markers were mea-
sured in a total of 517 subjects at 2 time-points, ranging between
2-5 years since baseline. Markers measured included, sCOMP,
sHA, uCTXII (normalized to urine creatinine for standardization),
sPIIANP, uCreatinine, uNTX, s846, xCPII, and serum hsCRP.
All biomarker data were log transformed. For each biomarker
and radiographic variable, the change is defined to be the dif-
ference between follow-up and baseline measures. Disease pro-
gression is defined as a positive change in any radiographic
measures.
Statistics: Participants with KL grades 3 or 4 in either hip at
baseline or with knee lateral minimum joint space (at base-
line or follow-up) of less than 3mm were excluded. Analysis
was conducted on the remaining 474 subjects. Radiographic
measurements of interest were summed from both knees and
hips. Parameters of interest included KL-Grades, Os scores
and JSN. Of interest are the relationships between 1) base-
line biomarker and baseline radiographic data, 2) between the
change in biomarker and baseline radiographic data, and 3)
between change in biomarker and radiographic OA progres-
sion. Simple linear regression was used to explore relationships
between biomarker and radiographic variables; Pearson’s corre-
lation coefficients are reported.
Results: Significant Pearson’s correlations were observed with
baseline sHA and uCTXII, markers of inflammation and collagen
degradation (Table) with respect to Os, JSN and KL grade.
Correlations with the remainder of the biomarkers were not
significant.
Differences in correlation between sHA and KL grade were
observed to be stronger among women, while the correlation be-
tween uCTXII and Os were stronger in men. Correlation between
sHA and Os is positive for females, but negative for males.
Baseline Sum
KL Grade OS NAR n
Baseline log_uCTXIIb ALL 0.169* 0.180** 0.131* 224
Females 0.182* 0.129 0.140 179
Males 0.114 0.324** 0.098 49
Baseline log sHab All 0.239**** 0.106 0.259**** 288
Females 0.252*** 0.174** 0.258*** 232
Males 0.158 -0.156 0.236 57
*p<0.05, **p<0.01, ***p <0.005, ****p <0.001.
Baseline uCTXII and change in JSN were correlated (r=0.147;
p<0.05), with correlation among females (males) being r = 0.201
(r = -0.069). Baseline sHa and change in JSN were correlated
(r = 0.160, p < 0.005); similar correlations were observed when
males and females were evaluated separately. When considering
the correlations between change in biomarkers and change in
radiographic parameters, a significant correlation was observed
in the change in uCTXII and change in JSN in males, r = 0.290.
Conclusions: Findings suggest that baseline biomarker levels
are reflective of radiographically determined disease severity and
progression, with observed gender differences.
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Purpose: To investigate whether patients with increased urinary
levels of type II collagen C-telopeptide (UCTX-II) at baseline
have an elevated risk to develop radiographic progression of
osteoarthritis (OA) in the knee after two years.
Methods: 208 patients (104 sibling pairs) from the Genetics,
Artrosis and Progression study (GARP), with symptomatic famil-
ial OA at multiple joint sites, were followed for two years. UCXT-II
levels were measured with an enzyme-linked immunosorbent
assay at baseline. Radiographs were taken at baseline and af-
ter two years. Knee OA was diagnosed when the Kellgren and
Lawrence score of one or both knees was equal to or larger than
two, or if the joint had been replaced by arthroplasty. Two ex-
perienced readers scored the paired radiographs conservatively
in consensus with the chronological order unknown. Joint space
narrowing (JSN) was scored using the OARSI atlas and graded
on a scale of 0 to 3 (0 = normal joint space to 3 = maximum
JSN). The JSN scores in the medial en lateral compartment
in both knees were summated. We defined progression as a
minimum of one point increase in total JSN score in patients
